Financhill
Back

Royalty Pharma PLC Vs. Arbutus Biopharma Industry Stock Comparison

Sell
30

RPRX
Royalty Pharma PLC

Last Price:
26.38
Seasonality Move:
1.9%
Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.46
Seasonality Move:
15.21%
Sell
30
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $26.22. The Score for RPRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.46. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $26.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 41.61 Sell
Chaikin Money Flow: 1431103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 30.71 Sell
Chaikin Money Flow: -475329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.61 - 4.03) Sell
Bollinger Bands (100): (3.57 - 4.13) Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.94 Buy
20-day SMA: 26.58 Sell
50-day SMA: 27.34 Sell
200-day SMA: 28.05 Sell
8-day EMA: 26.07 Buy
20-day EMA: 26.5 Sell
50-day EMA: 27.08 Sell
200-day EMA: 27.99 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.56 Sell
20-day SMA: 3.76 Sell
50-day SMA: 3.9 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.56 Sell
20-day EMA: 3.71 Sell
50-day EMA: 3.82 Sell
200-day EMA: 3.43 Buy

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.31 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):